ArticleEClinicalMedicine2024

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension.

Smeeta Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.